|
Market Closed -
Other stock markets
|
After hours 01:01:00 | |||
| 1,112.00 USD | -0.94% |
|
1,112.00 | 0.00% |
| 06-17 | Big pharma taps UK playbook to pressure Europe on drug prices | RE |
| 06-17 | Big pharma taps UK playbook to pressure European capitals on drug prices | RE |
| Market Cap | 1,001B 870B 801B 753B 1,410B 94,608B 1,427B 9,505B 3,691B 46,472B 3,757B 3,676B 160,771B | P/E 2026 * |
32.8x | P/E 2027 * | 26.6x |
|---|---|---|---|---|---|
| Enterprise Value | 1,018B 885B 814B 766B 1,435B 96,257B 1,452B 9,671B 3,755B 47,282B 3,822B 3,740B 163,575B | EV / Sales 2026 * |
11.9x | EV / Sales 2027 * | 10.2x |
| Free-Float |
99.84% | Yield 2026 * |
0.61% | Yield 2027 * | 0.67% |
Last Transcript: Eli Lilly and Company
| 1 day | -0.94% | ||
| 1 week | -2.85% | ||
| Current month | +0.63% | ||
| 1 month | +10.66% | ||
| 3 months | +12.42% | ||
| 6 months | +5.47% | ||
| Current year | +3.47% |
| 1 week | 1,104.9 |  | 1,170.12 |
| 1 month | 978.87 | | 1,182.73 |
| Current year | 850.51 | | 1,182.73 |
| 1 year | 623.78 | | 1,182.73 |
| 3 years | 434.34 | | 1,182.73 |
| 5 years | 217 | | 1,182.73 |
| 10 years | 64.18 | | 1,182.73 |
| Manager | Title | Age | Since |
|---|---|---|---|
David Ricks
CEO | Chief Executive Officer | 58 | 01/01/2017 |
Lucas Montarce
DFI | Director of Finance/CFO | 49 | 09/09/2024 |
| Chief Tech/Sci/R&D Officer | 52 | - |
| Director | Title | Age | Since |
|---|---|---|---|
Jon Fyrwald
BRD | Director/Board Member | 65 | 01/01/2005 |
Ralph Alvarez
BRD | Director/Board Member | 70 | 01/04/2009 |
| Director/Board Member | 54 | 12/12/2011 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 06-10 | Sell | Executive/Senior Manager | -2,500 | 0.0003% | ||
| 05-18 | Free | Director | 13 | 0.0000% | ||
| 05-18 | Free | Director | 5 | 0.0000% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -0.94% | -2.85% | +37.70% | +148.38% | 1,001B | |
| -0.42% | -1.18% | +50.88% | +42.60% | 566B | |
| -0.56% | -1.86% | +15.91% | +59.57% | 393B | |
| -1.18% | +2.29% | +24.04% | +16.53% | 326B | |
| +1.09% | +2.21% | +25.56% | +33.32% | 276B | |
| +1.42% | -1.17% | +24.53% | +14.29% | 277B | |
| +1.87% | +5.96% | -42.67% | -48.26% | 193B | |
| -1.78% | -0.84% | +15.60% | +48.77% | 188B | |
| -1.40% | -0.04% | +13.19% | +59.08% | 158B | |
| -0.46% | +0.86% | +6.23% | -35.30% | 148B | |
| Average | +0.08% | +0.45% | +17.10% | +33.90% | 352.52B | |
| Weighted average by Cap. | -0.22% | -0.33% | +26.15% | +61.99% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 85.28B 74.14B 68.2B 64.15B 120B 8,060B 122B 810B 314B 3,959B 320B 313B 13,697B | 98.16B 85.34B 78.5B 73.84B 138B 9,277B 140B 932B 362B 4,557B 368B 360B 15,766B |
| Net income | 30.99B 26.94B 24.78B 23.31B 43.66B 2,929B 44.17B 294B 114B 1,439B 116B 114B 4,977B | 37.83B 32.89B 30.26B 28.46B 53.31B 3,576B 53.93B 359B 140B 1,757B 142B 139B 6,077B |
| Net Debt | 17.45B 15.17B 13.96B 13.13B 24.59B 1,650B 24.88B 166B 64.35B 810B 65.5B 64.1B 2,803B | -3.03B -2.63B -2.42B -2.28B -4.27B -286B -4.32B -28.77B -11.17B -141B -11.37B -11.13B -487B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 17/06/26 | 1,112.00 $ | -0.94% | 2,379,932 |
| 16/06/26 | 1,122.50 $ | -0.61% | 2,260,747 |
| 15/06/26 | 1,129.35 $ | -0.32% | 3,167,157 |
| 12/06/26 | 1,133.00 $ | -2.41% | 2,438,390 |
| 11/06/26 | 1,160.95 $ | +2.16% | 2,764,934 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- LLY Stock
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition